- CRS Publications
- News
News
Authors:
Date:
CRS Statement Regarding U.S. White House Immigration Policies Dear CRS Members,
The White House has recently issued an Executive Order that places restrictions on travel to the U.S. for citizens of several countries.…
Authors:
Date:
PRNewswire: June 14, 2017 – CHAPEL HILL, NC, U.S.A. – Achelios Therapeutics, a privately held pharmaceutical development company focused on innovative topical drug delivery technologies, announced today it has completed a Type C meeting with the FDA regarding a path to approval for TOPOFEN™ in…
Authors:
Date:
Business Wire: June 12, 2017 – SAN DIEGO, CA, U.S.A. – Ensysce Biosciences Inc. has been invited to attend conference Cutting Edge Science Meeting Series to End the Opioid Crisis: Development of Safe, Effective, Non-Addictive Pain Treatments taking place June 16, 2017, at the National Institutes of…
Authors:
Date:
PRNewswire: June 5, 2017 – BOSTON, MA, U.S.A. – Landmark clinical data presented today highlight a scientific breakthrough in the management of sleep with a drug-free, non-prescription sleep product, REMfresh® , the first and only, continuous release and absorption melatonin (CRA-melatonin) to…
Authors:
Date:
Business Wire: June 1, 2017 – VANCOUVER, BC, Canada – Aequus Pharmaceuticals Inc. (TSX-V: AQS, OTCQB: AQSZF) (“Aequus”) a specialty pharmaceutical company with expertise in drug delivery and clinical development, and the Centre For Drug Research and Development (“CDRD”), Canada’s national drug…
Authors:
Date:
Introduction
Many promising therapeutic compounds suffer from disadvantages such as low bioavailability, rapid clearance, and high systemic toxicity. To overcome these challenges, nanoparticles such as polymersomes can be used as promising drug delivery systems. Polymersomes are vesicles formed by…
